Rheumatologic Disease study: Patient Navigation
Official title Testimonials and Navigation in Rheumatology
ClinicalTrials.gov ID: NCT06469788
What this study is testing
- What it's testing
- The study wants to find out whether a new, multi‑modal behavioral program can increase uptake of the updated COVID‑19 vaccine among rheumatology patients.
- Who it's for
- Adults with rheumatologic or other autoimmune diseases who are being treated in rheumatology clinics.
- What's involved
- Participants will receive a patient‑directed behavioral intervention that may include education, reminders, and other support tools, along with usual care, and will complete related surveys or assessments.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults (18+ years) with known AIRD
- Black race and/or Latinx ethnicity
- Individuals who have not obtained the updated COVID-19 vaccine series (self-report)
You likely can't join if
- -Lack of access to phone
The study team makes the final eligibility decision.
Where it is enrolling
- Birmingham, Alabama, United States
- Evanston, Illinois, United States
- Boston, Massachusetts, United States
- Worcester, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Birmingham, Alabama, United States; Evanston, Illinois, United States; Boston, Massachusetts, United States; Worcester, Massachusetts, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.